Innovation is expensive. We have known that.
Editor's note · Context
Acknowledgment of the high costs associated with medical innovation.
Share
More from Richard Burr
I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.
We have the tools, tests, and vaccinations, therefore, there is no longer a public health reason to bar people from entering this country.
I rise today in the time-honored tradition of giving my farewell remarks to the United States Senate. This is an opportunity to thank my friends, my colleagues, and the voters of North Carolina who have supported me for 28 years, through 8…
it is clearly apparent by listening to this debate, if Senator Sanders had been on the PEB board, the PEB board wouldn't be making a recommendation and the President wouldn't be behind it. But that is where we are, short of a breakthrough…





